Dupixent (dupilumab) is a biologic medication used to treat moderate to severe atopic dermatitis (eczema) in people who haven't responded well to topical treatments or other systemic therapies. It works by targeting specific parts of the immune system to reduce inflammation and prevent flare-ups.
NICE (National Institute for Health and Care Excellence) has approved Dupixent for:
Adults and children aged 6 and above with moderate-to-severe eczema
Must have tried topical steroids and at least one systemic treatment (like cyclosporine, methotrexate, or azathioprine)
Eczema must significantly impact quality of life (e.g., sleep disruption, frequent infections)
Private Treatment Costs
If not eligible via NHS, private prescriptions cost around £1,300 per month. Private insurance may cover it, but policies vary.
Common side effects include:
Regular Monitoring
Regular eye exams may be needed. Report any new symptoms to your healthcare team promptly.